ECO Animal Health shareholders approve employee benefit trust share buyback

Published 21/08/2025, 12:34
ECO Animal Health shareholders approve employee benefit trust share buyback

LONDON - ECO Animal Health Group plc (AIM:EAH) announced Thursday that shareholders approved a special resolution at the company’s General Meeting, authorizing trustees of the ECO Animal Health Employee Benefit Trust to begin limited on-market purchases of the company’s ordinary shares.

The veterinary pharmaceutical company, which specializes in antibiotics and vaccines for pigs and poultry, held the General Meeting earlier today where the single special resolution was passed. The resolution specifically allows for the purchase of the company’s ordinary shares with a nominal value of 5 pence each.

The company indicated in its press release statement that voting results from the General Meeting will be made available on its corporate website.

ECO Animal Health describes itself as a global animal health company with operations spanning over 70 countries and a workforce exceeding 200 employees worldwide. The company maintains a portfolio of marketed veterinary products, including its lead product Aivlosin®, a proprietary medication for treating respiratory and intestinal diseases in pigs and poultry.

The company also noted it has a developing research and development pipeline of veterinary pharmaceuticals.

ECO Animal Health Group is dual-listed with Singer Capital Markets serving as its Nominated Adviser and Joint Broker, alongside Investec (LON:INVP) as Joint Broker.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.